Agilent Technologies · 3 days ago
Field Application Scientist
Agilent Technologies is seeking a highly motivated Field Application Scientist to join their Cell Analysis team in the Bay Area. The role involves engaging with customers to support research in life sciences, focusing on live cell analysis and related instrumentation.
BiotechnologyHealth CareHealth DiagnosticsLife SciencePharmaceutical
Responsibilities
Provide field-based & remote scientific engagement with customers in both pre/post-sales capacities; from focused 1:1 consultation, to product demonstrations and applications-focused training & assay optimization
Develop expertise with instrument hardware/software while keeping abreast of current assays/workflows as well as emerging applications
Convey customers’ voice and feedback to product management to promote innovation and address evolving market requirements
Qualification
Required
M.S. or PhD in Neuroscience, Immunology, Microbiology, or related field with applicable live-cellular training
Preferred
PhD is strongly preferred
2+ years' of strong academic or industrial experience using microscopy or flow cytometry and live cell handling preferred
1+ years' of industrial experience, preferably as a Field Application Scientist preferred
Experience using Agilent BioTek, Seahorse, and ACEA products a plus
Benefits
Eligibility for bonus
Stock
Benefits
Choice of company car or reimbursement for personal vehicle usage
Company
Agilent Technologies
Agilent Technologies addresses the scientific and laboratory management needs of analytical scientists and clinical researchers.
H1B Sponsorship
Agilent Technologies has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (51)
2024 (56)
2023 (58)
2022 (70)
2021 (64)
2020 (53)
Funding
Current Stage
Public CompanyTotal Funding
$500M2019-09-05Post Ipo Debt· $500M
1999-11-26IPO
Recent News
2026-01-16
Research & Development World
2026-01-09
Company data provided by crunchbase